Rik J. Verheijden

Utrecht, UT 3584CG, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

AI-based histopathology analysis predicts checkpoint inhibitor response in advanced melanoma and identifies patterns associated with response.

AI-based histopathology analysis predicts checkpoint inhibitor response in advanced melanoma and identifies patterns associated with response.

Journal: European journal of cancer (Oxford, England : 1990)

Published: March 20, 2026

Author Correction: Blood and tissue correlates of steroid non-response in checkpoint inhibition-induced immune-related adverse events.

Author Correction: Blood and tissue correlates of steroid non-response in checkpoint inhibition-induced immune-related adverse events.

Journal: Communications medicine

Published: January 23, 2026

Checkpoint inhibitor effectiveness after corticosteroids and second-line immunosuppressants for immune-related adverse events in non-small-cell lung cancer.

Checkpoint inhibitor effectiveness after corticosteroids and second-line immunosuppressants for immune-related adverse events in non-small-cell lung cancer.

Journal: ESMO open

Published: October 17, 2025

Checkpoint inhibitor effectiveness after corticosteroids and second-line immunosuppressants for immune-related adverse events in non-small-cell lung cancer.

Checkpoint inhibitor effectiveness after corticosteroids and second-line immunosuppressants for immune-related adverse events in non-small-cell lung cancer.

Journal: ESMO open

Published: October 17, 2025

Artificial Intelligence-Detected Tumor-Infiltrating Lymphocytes and Outcomes in Anti-PD-1-Based Treated Melanoma.

Artificial Intelligence-Detected Tumor-Infiltrating Lymphocytes and Outcomes in Anti-PD-1-Based Treated Melanoma.

Journal: JAMA oncology

Published: October 16, 2025

Blood and tissue correlates of steroid non-response in checkpoint inhibition-induced immune-related adverse events.

Blood and tissue correlates of steroid non-response in checkpoint inhibition-induced immune-related adverse events.

Journal: Communications medicine

Published: March 05, 2025

Gut microbiome and immune checkpoint inhibitor toxicity.

Gut microbiome and immune checkpoint inhibitor toxicity.

Journal: European journal of cancer (Oxford, England : 1990)

Published: December 13, 2024

Reply to: Peak Corticosteroid Dose for Immune-Related Adverse Events and Survival: Not the Whole Story.

Reply to: Peak Corticosteroid Dose for Immune-Related Adverse Events and Survival: Not the Whole Story.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: November 15, 2024

Corticosteroids for Immune-Related Adverse Events and Checkpoint Inhibitor Efficacy: Analysis of Six Clinical Trials.

Corticosteroids for Immune-Related Adverse Events and Checkpoint Inhibitor Efficacy: Analysis of Six Clinical Trials.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: August 07, 2024

Tumor-infiltrating lymphocytes and immune-related adverse events in advanced melanoma.

Tumor-infiltrating lymphocytes and immune-related adverse events in advanced melanoma.

Journal: Immuno-oncology technology

Published: July 24, 2024

Anti-PD-1 treatment response is associated with the influx of circulating myeloid and T-cell subsets into the metastatic melanoma tumor microenvironment.

Anti-PD-1 treatment response is associated with the influx of circulating myeloid and T-cell subsets into the metastatic melanoma tumor microenvironment.

Journal: British journal of cancer

Published: May 31, 2024

Next-generation IgA-SEQ allows for high-throughput, anaerobic, and metagenomic assessment of IgA-coated bacteria.

Next-generation IgA-SEQ allows for high-throughput, anaerobic, and metagenomic assessment of IgA-coated bacteria.

Journal: Microbiome

Published: May 29, 2024

Showing 1-12 of 33

Last Updated: 09/26/2026